Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Income Quality Over TimeContracting
Percentile Rank33
3Y CAGR+18.2%
5Y CAGR+2.0%
Studio
Year-over-Year Change

Quality of reported income

3Y CAGR
+18.2%/yr
Annual compound
5Y CAGR
+2.0%/yr
Recent acceleration
Percentile
P33
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
20250.58-25.6%
20240.77-11.7%
20230.88+151.5%
20220.35-59.0%
20210.85+63.0%
20200.52-43.4%
20190.92-